In between constantly managing regulatory affairs submissions for our clients and dealing with some of the most dynamic healthcare companies around the world, our team has picked 5 of the top stories from the last thirty days. Amidst a business landscape of takeover, mergers and job announcements, there have been many stories that have caught the attention of Acorn Regulatory staff. Here are our top 5.
Read Peter Lurie from the FDA’s opinion piece here.
Bloomberg Technology are covering this fascinating story.
RAPS related tweets for you to enable you to get a flavour of what happened at the conference.
You can read more from the blog here.